Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NASDAQ: CRBP · IEX Real-Time Price · USD

48.01

-1.39 (-2.81%)

At close: Jul 2, 2024, 4:00 PM

48.03

+0.02 (0.04%)

After-hours: Jul 2, 2024, 6:40 PM EDT

CRBP Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-44.6	-42.35	-45.64	-111.27	-71.45	Upgrade
Depreciation & Amortization	0.64	0.76	1.64	1.69	1.23	Upgrade
Share-Based Compensation	3.47	5.72	9.48	12.46	11.98	Upgrade
Other Operating Activities	4.39	-1.68	-13.66	-2.57	12.52	Upgrade
Operating Cash Flow	-36.1	-37.54	-48.18	-99.69	-45.72	Upgrade
Capital Expenditures	0	-0.01	-0.03	-0.48	-2.74	Upgrade
Change in Investments	35.64	30.08	-73.39	0	0	Upgrade
Investing Cash Flow	35.64	30.07	-73.42	-0.48	-2.74	Upgrade
Share Issuance / Repurchase	0.24	0	62.59	142.2	40.68	Upgrade
Debt Issued / Paid	-2.87	-0.53	0.06	18.71	0.36	Upgrade
Other Financing Activities	-0.19	-	-1.82	-6.04	-2.57	Upgrade
Financing Cash Flow	-2.82	-0.53	60.82	154.87	38.46	Upgrade
Net Cash Flow	-3.28	-8	-60.78	54.7	-10	Upgrade
Free Cash Flow	-36.1	-37.55	-48.21	-100.17	-48.46	Upgrade
Free Cash Flow Margin	-	-	-5468.27%	-2544.18%	-134.09%	Upgrade
Free Cash Flow Per Share	-8.34	-9.00	-11.77	-38.46	-22.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).